(a) medical literacy research that identifies factors that improve understandability of labels and promotes increased compliance with a drug's intended use;
(b) factors that improve the clarity of directions for use;
(c) font types and sizes;
(d) inclusion of only patient-centered information; and
(e) the needs of special populations. To ensure public input, the commissioner shall solicit input from the state board of pharmacy and the state board of medicine, consumer groups, advocates for special populations, pharmacists, physicians, other health care professionals authorized to prescribe, and other interested parties.